As expected, treatment of T2D rats with PAP1 significantly reduced the plasma levels of eight cytokines: IL-1b, IL-4, IL-5, IL-10, IL-12p70, GM-CSF, IFNγ, and TNFα. This evidence concerns the gene TNF and type 2 diabetes mellitus.